Your browser doesn't support javascript.
loading
The Cooperative Human Tissue Network of the National Cancer Institute: Supporting Cancer Research for 35 Years.
McCall, Shannon J; Lubensky, Irina A; Moskaluk, Christopher A; Parwani, Anil; Radin, Kiley; Ramirez, Nilsa C; Von Menchhofen, Zachery; Washington, Mary K; LiVolsi, Virginia A.
Afiliación
  • McCall SJ; Department of Pathology, Duke University School of Medicine and Duke Cancer Institute, Durham, North Carolina.
  • Lubensky IA; NCI, NIH, Bethesda, Maryland.
  • Moskaluk CA; Department of Pathology, University of Virginia, Charlottesville, Virginia.
  • Parwani A; Department of Pathology, The Ohio State University, Columbus, Ohio.
  • Radin K; NCI, NIH, Bethesda, Maryland.
  • Ramirez NC; Nationwide Children's Hospital, Columbus, Ohio.
  • Von Menchhofen Z; Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Washington MK; Department of Pathology, Vanderbilt University, Nashville, Tennessee.
  • LiVolsi VA; Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania.
Mol Cancer Ther ; 22(10): 1144-1153, 2023 Oct 02.
Article en En | MEDLINE | ID: mdl-37523711
The Cooperative Human Tissue Network was created by the NCI in 1987 to support a coordinated national effort to collect and distribute high quality, pathologist-validated human tissues for cancer research. Since then, the network has expanded to provide different types of tissue samples, blood and body fluid samples, immunohistologic and molecular sample preparations, tissue microarrays, and clinical datasets inclusive of biomarkers and molecular testing. From inception through the end of 2021, the network has distributed 1,375,041 biospecimens. It served 889 active investigators in 2021. The network has also taken steps to begin to optimize the representation of diverse communities among the distributed biospecimens. In this article, the authors review the 35-year history of this network, describe changes to the program over the last 15 years, and provide operational and scientific highlights from each of the divisions. Readers will learn how to engage with the network and about the continued evolution of the program for the future.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2023 Tipo del documento: Article